🇺🇸 Lamivudine 300 MG in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abortion Induced — 1 report (10%)
  2. Acute Respiratory Failure — 1 report (10%)
  3. Anencephaly — 1 report (10%)
  4. Arnold-Chiari Malformation — 1 report (10%)
  5. Death — 1 report (10%)
  6. Drug Eruption — 1 report (10%)
  7. Drug-Induced Liver Injury — 1 report (10%)
  8. Dyspnoea — 1 report (10%)
  9. Erythema — 1 report (10%)
  10. Hydrocephalus — 1 report (10%)

Source database →

Lamivudine 300 MG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Lamivudine 300 MG approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Lamivudine 300 MG in United States?

Fundacion Clinic per a la Recerca Biomédica is the originator. The local marketing authorisation holder may differ — check the official source linked above.